APA

Ventriglia J., Petrillo A., Huerta Alváro M., Laterza M. M., Savastano B., Gambardella V., Tirino G., Pompella L., Diana A., Iovino F., Troiani T., Martinelli E., Morgillo F., Orditura M., Cervantes A., Ciardiello F. & De Vita F. (2018). Neutrophil to Lymphocyte Ratio as a Predictor of Poor Prognosis in Metastatic Pancreatic Cancer Patients Treated with Nab-Paclitaxel plus Gemcitabine: A Propensity Score Analysis. : Gastroenterology research and practice.

Chicago

Ventriglia J, Petrillo A, Huerta Alváro M, Laterza M M, Savastano B, Gambardella V, Tirino G, Pompella L, Diana A, Iovino F, Troiani T, Martinelli E, Morgillo F, Orditura M, Cervantes A, Ciardiello F and De Vita F. 2018. Neutrophil to Lymphocyte Ratio as a Predictor of Poor Prognosis in Metastatic Pancreatic Cancer Patients Treated with Nab-Paclitaxel plus Gemcitabine: A Propensity Score Analysis. : Gastroenterology research and practice.

Harvard

Ventriglia J., Petrillo A., Huerta Alváro M., Laterza M. M., Savastano B., Gambardella V., Tirino G., Pompella L., Diana A., Iovino F., Troiani T., Martinelli E., Morgillo F., Orditura M., Cervantes A., Ciardiello F. and De Vita F. (2018). Neutrophil to Lymphocyte Ratio as a Predictor of Poor Prognosis in Metastatic Pancreatic Cancer Patients Treated with Nab-Paclitaxel plus Gemcitabine: A Propensity Score Analysis. : Gastroenterology research and practice.

MLA

Ventriglia J, Petrillo A, Huerta Alváro M, Laterza M M, Savastano B, Gambardella V, Tirino G, Pompella L, Diana A, Iovino F, Troiani T, Martinelli E, Morgillo F, Orditura M, Cervantes A, Ciardiello F and De Vita F. Neutrophil to Lymphocyte Ratio as a Predictor of Poor Prognosis in Metastatic Pancreatic Cancer Patients Treated with Nab-Paclitaxel plus Gemcitabine: A Propensity Score Analysis. : Gastroenterology research and practice. 2018.